Additionally, the lower expression of BIRC3 in HK4-treated cells might also play a protective role in our cell model, since inhibition of BIRC3 reduced hepatocellular carcinoma and progression of metastases (Fu et al., 2019; Frazzi, 2021). Here, BIRC3 is linked to hepatocellular carcinoma.